Cell-associated activation of latent transforming growth factor-β by calpain

被引:0
|
作者
Abe, M [1 ]
Oda, N [1 ]
Sato, Y [1 ]
机构
[1] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Aoba Ku, Sendai, Miyagi 98077, Japan
关键词
D O I
10.1002/(SICI)1097-4652(199802)174:2<186::AID-JCP6>3.0.CO;2-K
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor-beta (TGF-beta) is normally secreted in a latent form, and plasmin-mediated proteolytic cleavage of latency-associated peptide (LAP), a component of latent TGF-beta complex that makes the complex inactive, activates latent TGF-beta. In the present study, we investigated the possible involvement of calpain, one of the cysteine proteases, in the activation of latent TGF-beta. When recombinant latent TGF-beta was incubated with calpain (1-10 u/ml) in a test tube, calpain cleaved LAP and released mature TGF-beta from the latent complex. When calpain was applied to cultured bovine capillary endothelial (BCE) cells, a low concentration of calpain (0.05-0.1 u/ml) inhibited the migration and proliferation of the cells, and these inhibitory effects were abrogated by anti-TGF-beta antibody as well as by calpain inhibitor peptide, but not by alpha(2)-antiplasmin, a specific inhibitor of plasmin. Active TGF-beta was detected in the conditioned medium of BCE cells collected in the presence of calpain. Chemical cross-linking of I-125-calpain to BCE cells followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis indicated that calpain bound to the cell surface through chondroitinase ABC-sensitive proteoglycan. In addition, treatment of the BCE cells with chondroitinase ABC abrogated the inhibitory effect of calpain on the migration of these cells. Our data thus suggest that calpain is able to activate latent TGF-beta through a mechanism independent of plasmin. This activation is efficient in the presence of cells, and calpain binds to the cell surface via proteoglycan and activates latent TGF-beta, which is targeted to the same surface. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:186 / 193
页数:8
相关论文
共 50 条
  • [31] Endopyelotomy failure is associated with reduced transforming growth factor-β
    Jabbour, ME
    Goldfischer, ER
    Anderson, AE
    Smith, AD
    Kushner, L
    JOURNAL OF UROLOGY, 1998, 160 (06): : 1991 - 1994
  • [32] Extracellular matrix-associated transforming growth factor-β:: Role in cancer cell growth and invasion
    Taipale, J
    Saharinen, J
    Keski-Oja, J
    ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 : 87 - 134
  • [33] Transforming growth factor-β receptors: versatile mechanisms of ligand activation
    Chia, Zheng-Jie
    Cao, Ying-nan
    Little, Peter J.
    Kamato, Danielle
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (07) : 1337 - 1348
  • [34] Activation of transforming growth factor-β1 in diabetic kidney disease
    Hellmich, B
    Schellner, M
    Schatz, H
    Pfeiffer, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (03): : 353 - 359
  • [35] Transforming Growth Factor-β Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor-β Signaling and Risk for Systemic Sclerosis
    Hinchcliff, Monique E.
    Pennison, Michael
    Zimmerman, Jacquelyn
    Bellam, Naresh
    Zeng, Qinghua
    Huang, Chiang-Ching
    Pope, Richard M.
    Sadim, Maureen
    Wolf, Wendy
    Edberg, Jeffrey C.
    Kimberly, Robert P.
    Zhang, Kui
    Li, Jun
    Yi, Nengjun
    Mayes, Maureen D.
    Varga, John
    Pasche, Boris
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S903 - S903
  • [36] Transforming growth factor-β and breast cancer -: Tumor promoting effects of transforming growth factor-β
    Dumont, N
    Arteaga, CL
    BREAST CANCER RESEARCH, 2000, 2 (02): : 125 - 132
  • [37] Latent transforming growth factor-β activation in mammary gland -: Regulation by ovarian hormones affects ductal and alveolar proliferation
    Ewan, KB
    Shyamala, G
    Ravani, SA
    Tang, Y
    Akhurst, R
    Wakefield, L
    Barcellos-Hoff, MH
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06): : 2081 - 2093
  • [38] Transforming growth factor-β in T-cell biology
    Gorelik, L
    Flavell, RA
    NATURE REVIEWS IMMUNOLOGY, 2002, 2 (01) : 46 - 53
  • [39] Transforming growth factor-β in T-cell biology
    Leonid Gorelik
    Richard A. Flavell
    Nature Reviews Immunology, 2002, 2 : 46 - 53
  • [40] Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β
    F Vincent
    M Nagashima
    S Takenoshita
    M A Khan
    A Gemma
    K Hagiwara
    W P Bennett
    Oncogene, 1997, 15 : 117 - 122